Arcadia Biosciences, Inc. (RKDA) produces and markets innovative, plant-based health and wellness products. The company significantly expanded its distribution of body care products, which bodes well for continued retail growth. However, its forward P/S of 4.13x is 235% higher than the industry average of 1.23x.
The stock has lost 32% over the past six months and 50.2% over the past year. Moreover, concerns over supply chain issues and rising input costs make its near-term prospects bleak.
